2004 Safety Treatment 
The Cannigma
JULY 18, 2025
Medical patients like Olivia often stop shopping at dispensaries when they can no longer find the specialized products they need for their treatment. Without these foundational frameworks, patients are left to navigate cannabis treatments on their own, often at great risk (AJMC, 2022).
Cannabis Law Report
DECEMBER 1, 2021
Ethics, Safety, and Abuse in Psychedelic Medicine. She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS. Wednesday, December 8th from 12:00-2:00pm PST.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 23, 2020
the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no. 852/2004 of the European Parliament and of. Council of 29 April 2004 on the hygiene of food products; Having regard to Regulation (EC) no. 853/2004 of the European Parliament and of. 178/2002 no.
CannaMD
OCTOBER 23, 2019
Nausea and vomiting are the body’s equivalent of a trouble light and a safety valve. Medical conditions such as HIV/AIDS and cancer , and their related treatments, can also cause extreme nausea. Cannabis has long been recognized as an effective treatment for HIV/AIDS symptoms and medication side effects.
SpeedWeed
APRIL 27, 2021
On Friday, lawmakers in the Montana Senate passed a bill establishing a framework for the nascent program, including a provision that “would reserve tax revenue from sales for addiction treatment and statewide conservation efforts,” according to the Associated Press. The signatures were officially certified in August of last year. .
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.
Cannabis Law Report
JUNE 25, 2021
Professor David Nutt commented, “I am delighted to take on the role of Chief Research Officer in this exciting new biotechnology company that promises to revolutionise the treatment of addictions. Awakn’s combination of pre-clinical and clinical research uniquely positions Awakn to solve some of the biggest societal problems.”.
Expert insights. Personalized for you.
Let's personalize your content